@article{5cda638769bc40b49c18295d38e7acd2,
title = "Bacterial Brain Abscess: An Outline for Diagnosis and Management",
abstract = "Despite advances in the diagnosis and management of brain abscess, significant associated morbidity and mortality remain high. We retrospectively reviewed adults who presented with pyogenic brain abscess from January 1, 2009, through June 30, 2020. Overall, 247 patients were identified. The median age was 59 years, and 33.6% had a history of head and neck surgery or traumatic brain injury. Diagnostic brain magnetic resonance imaging (MRI) was performed in the bulk (93.1%) of patients. A total of 205 patients (83%) were managed with medical and surgical treatment. The most common definitive antibiotic regimen was monotherapy (48.2%). The median duration of antimicrobial therapy was 42 days. Compared with those who received combined therapy, patients with medical therapy alone had a higher mortality rate (21.4% vs 6%; P =. 003) with more neurologic sequelae (31% vs 27.1%; P = .5). Most patients with brain abscesses are older with multiple underlying comorbidities, and one-third had antecedent head and neck surgery. A prompt combined surgical and medical approach with prolonged antimicrobial therapy may cure the infection with avoidance of permanent residual neurologic deficits.",
keywords = "Bacterial, Biopsy, Brain abscess, Cerebritis, Diagnosis, Immunocompromised, Management, Outcomes, Stereotactic, Surgery",
author = "{Corsini Campioli}, Cristina and {Castillo Almeida}, {Natalia E.} and O'Horo, {John C.} and {Esquer Garrigos}, Zerelda and Wilson, {Walter R.} and Edison Cano and DeSimone, {Daniel C.} and Baddour, {Larry M.} and {Van Gompel}, {Jamie J.} and Sohail, {M. Rizwan}",
note = "Funding Information: Funding: This publication was supported in part by NIH/NCRR/NCATS CTSA Grant Number UL1 TR002377. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Funding Information: Conflicts of Interest: JCO reports consulting fees from Bates College and Elsevier Inc. not related to the present work. LMB reports royalty payments (authorship duties) from UpToDate, Inc., and consulting fees from Boston Scientific, Botanix Pharmaceuticals, and Roivant Sciences over the past 12 months. MRS reports honoraria/consulting fee from Medtronic Inc., Philips, and Aziyo Biologics, Inc. (All <28 US$10K) and a research grant from Medtronic. CCC, NECA, ZEG, WRW, EC, DCDS, JJVG report none. Funding Information: Funding: This publication was supported in part by NIH/NCRR/NCATS CTSA Grant Number UL1 TR002377. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Conflicts of Interest: JCO reports consulting fees from Bates College and Elsevier Inc. not related to the present work. LMB reports royalty payments (authorship duties) from UpToDate, Inc., and consulting fees from Boston Scientific, Botanix Pharmaceuticals, and Roivant Sciences over the past 12 months. MRS reports honoraria/consulting fee from Medtronic Inc., Philips, and Aziyo Biologics, Inc. (All <28 US$10K) and a research grant from Medtronic. CCC, NECA, ZEG, WRW, EC, DCDS, JJVG report none. Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",
year = "2021",
month = oct,
doi = "10.1016/j.amjmed.2021.05.027",
language = "English (US)",
volume = "134",
pages = "1210--1217.e2",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "10",
}